The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Corvus Pharmaceuticals develops immuno-oncology therapies, with a clinical pipeline focused on monoclonal antibodies and small molecule inhibitors targeting cancer and immune disorders. The company ...
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) on Thursday released new interim data from the Phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. Overall, ...
Corvus Pharmaceuticals (CRVS) jumped ~66% in the premarket on Tuesday after the clinical-stage biotech announced plans to initiate a mid-stage trial for its lead asset, soquelitinib, for a skin ...
NEW YORK--(BUSINESS WIRE)--The Travelers Companies, Inc. (NYSE: TRV) today announced that it has agreed to acquire Corvus Insurance Holdings, Inc. for approximately $435 million. Founded in 2017, ...
BOSTON--(BUSINESS WIRE)--Corvus Insurance, the leading cyber underwriter powered by a proprietary AI-driven cyber risk platform, today announced its U.S. industry-leading 2022 ultimate loss ratio of ...
Shares of Corvus Pharmaceuticals CRVS have skyrocketed 208.8% in a month. The massive stock price rally was observed after the company announced positive results from cohort 4 of an early-stage study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results